Virginia Spielmann, PhD, and Sarah A. Schoen, PhD, OTR/L. Executive Director (Dr. Spielmann) and Director of Research (Dr. Schoen), STAR Institute for Sensory Processing. Centennial, CO. Dr. Spielmann and Dr. Schoen, experts for this educational activity, have no relevant financial relationship(s) with ineligible companies to disclose.
Lee Wachtel, MD, Medical Director, Neurobehavioral Unit, Kennedy Krieger Institute. Psychiatry Professor, Johns Hopkins School of Medicine. Baltimore, MD.
Dr. Wachtel, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
Jennifer J. Thomas, PhD
Associate Professor of Psychology, Department of Psychiatry, Harvard Medical School.Co-director, Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA. Associate Editor for the International Journal of Eating Disorders.
Dr. Thomas has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Sarah Nutter, PhD
Assistant professor, Department of Educational Psychology and Leadership Studies, University of Victoria, BC, Canada. Member of EveryBODY Matters, a multidisciplinary partnership of weight bias and obesity stigma researchers engaging in advocacy and outreach.
Dr. Nutter has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
John C. Raiss, MD. Assistant Clinical Professor of Child and Adolescent Psychiatry, UCLA David Geffen School of Medicine, Los Angeles, CA. Dr. Raiss has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
RSS
